Fundraising Fox

Santi Therapeutics

Waltham, US · Founded 2019 · 1 known investors

Biotech

Founders & leadership

JR
Joshua ResnickDirector
DG
David GrayzelDirector
MD
Milind DeshpandeExecutive Officer, Director
SR
Simon ReadDirector

Investors · 1

Reported raises · per SEC filings

Form D private placements
$120.1MraisedDec 2025 · 20 investors · Pharmaceuticals
Rule 506(b)
$42.6MraisedApr 2022 · 14 investors · Pharmaceuticals
Rule 506(b)
$10MraisedSep 2021 · 1 investors · Pharmaceuticals
Rule 506(b)
$6MraisedJul 2020 · 3 investors · Pharmaceuticals
Rule 506(b)

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.